Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 3/12/2020
SIETES contiene 93177 citas

 
 
 1 a 20 de 287 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med 2020:24 de febrero. [Ref.ID 103548]
2.Enlace a cita original Cita con resumen
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLOS Medicine 2019:13 de marzo. [Ref.ID 103076]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
4. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
6.Tiene citas relacionadas Cita con resumen
Puttnam R, Davis BR, Pressel SL, Whelton PK, Cushman WC, Louis GT, Margolis KL, Oparil S, Williamson J, Ghosh A, Einhorn PT, Barzilay JI, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group.. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med 2017;177:67-76. [Ref.ID 101344]
7. Cita con resumen
Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf 2016;25:628-36. [Ref.ID 100019]
8. Cita con resumen
Anónimo. Indapamide + amlodipine. Prescrire 2015;35:7. [Ref.ID 98895]
10. Cita con resumen
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013;310:2544-53. [Ref.ID 96675]
11.Tiene citas relacionadas
Weber MA, Bakris GL, Weir MR, Jamerson K. Obesity, blood pressure, and cardiovascular outcomes - Authors' reply. Lancet 2013;381:1982. [Ref.ID 95608]
12.Tiene citas relacionadas
Dong S, Mao B. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1982. [Ref.ID 95607]
13.Tiene citas relacionadas
Blankfield RP. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95606]
14.Tiene citas relacionadas
Barrios V, Escobar C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95605]
15.Tiene citas relacionadas
Elijovich F, Laffer C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95604]
16.
Bramham K, Nelson-Piercy C, Brown MJ, Chappell LC. Postpartum management of hypertension. BMJ 2013;346:30-4. [Ref.ID 95393]
17.Tiene citas relacionadas Cita con resumen
Weber MA, Jamerson KB, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velázquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2013;381:537-45. [Ref.ID 94952]
18.Tiene citas relacionadas
Messerli FH, Bangalore S. Diuretic-based regimens for obese patients?. Lancet 2013;381:512-3. [Ref.ID 94951]
19. Cita con resumen
Pirmohamed M. Drug-grapefruit juice interactions. BMJ 2013;346:9. [Ref.ID 94758]
Seleccionar todas
 
 1 a 20 de 287 siguiente >>